EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microsatellite Instability in the Tumor Microenvironment: The Role of Inflammation and the Microbiome

Elizabeth Vargas-Castellanos iD, Andrés Rincón-Riveros iD

Cancer Medicine · 2025

DOI: 10.1002/cam4.70603 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2025. Verfasst von Elizabeth Vargas-Castellanos und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario Mayor-Mederi, Universidad del Rosario, Bogotá, Colombia. Hauptthemen laut MEDLINE: Tumor Microenvironment, Microsatellite Instability, Neoplasms, Inflammation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital Universitario Mayor Méderi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Microsatellite instability (MSI) is a hallmark of DNA mismatch repair (MMR) deficiency that leads to genomic instability and increased cancer risk. The tumor microenvironment (TME) significantly influences MSI‐driven tumorigenesis, and emerging evidence points to a critical role of the microbiome in shaping this complex interplay.

Methods

This review comprehensively examines the existing literature on the intricate relationship between MSI, microbiome, and cancer development, with a particular focus on the impact of microbial dysbiosis on the TME.

Results

MSI‐high tumors exhibited increased immune cell infiltration owing to the generation of neoantigens. However, immune evasion mechanisms such as PD‐1/CTLA‐4 upregulation limit the efficacy of immune checkpoint inhibitors (ICIs) in a subset of patients. Pathobionts, such as Fusobacterium nucleatum and Bacteroides fragilis, contribute to MSI through the production of genotoxins, further promoting inflammation and oxidative stress within the TME.

Conclusions

The microbiome profoundly affects MSI‐driven tumorigenesis. Modulation of the gut microbiota through interventions such as fecal microbiota transplantation, probiotics, and dietary changes holds promise for improving ICI response rates. Further research into cancer pharmacomicrobiomics, investigating the interplay between microbial metabolites and anticancer therapies, is crucial for developing personalized treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentMicrosatellite InstabilityNeoplasmsInflammationGastrointestinal MicrobiomeHumansAnimalsDysbiosisImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

carcinogenesisinflammationmicrobiomemicrosatellitesmismatch repair

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Hospital Universitario Mayor-Mederi, Universidad del Rosario, Bogotá, Colombia.
  • Facultad de Ciencias de la Salud, Universidad Colegio Mayor de Cundinamarca, Bogotá, Colombia.

ORCID-Profile: Elizabeth Vargas-Castellanos, Andrés Rincón-Riveros

Förderung

  • Hospital Universitario Mayor Méderi

Zitieren

APA

Vargas-Castellanos, E., & Rincón-Riveros, A. (2025). Microsatellite Instability in the Tumor Microenvironment: The Role of Inflammation and the Microbiome. Cancer Medicine. https://doi.org/10.1002/cam4.70603

Vancouver

Vargas-Castellanos E, Rincón-Riveros A. Microsatellite Instability in the Tumor Microenvironment: The Role of Inflammation and the Microbiome. Cancer Medicine. 2025. doi:10.1002/cam4.70603

BibTeX
@article{VargasCastellanos2025,
  author = {Vargas-Castellanos, Elizabeth and Rincón-Riveros, Andrés},
  title = {Microsatellite Instability in the Tumor Microenvironment: The Role of Inflammation and the Microbiome},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70603}
}
Kostenlos starten →